Nanomaterials in the Management of Gram-Negative Bacterial Infections [PDF]
Nanomaterials, 2021 The exploration of multiplexed bacterial virulence factors is a major problem in the early stages of Escherichia coli infection therapy. Traditional methods for detecting Escherichia coli (E.
Mahmood Barani +8 more
doaj +4 more sources
Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans
Pathogens and Immunity, 2022 Drug-resistant Gram-negative bacterial pathogens are an increasingly serious health threat causing worldwide nosocomial infections with high morbidity and mortality.
Panagiotis Zagaliotis +3 more
doaj +3 more sources
Antibiotics for the Treatment of Patients with Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacterial Infections [PDF]
AntibioticsInfections caused by MBL-producing Gram-negative bacterial pathogens have disseminated worldwide and are associated with considerable morbidity and mortality.
Matthew E. Falagas +3 more
doaj +2 more sources
Characteristics and risk factors of secondary bacterial infections in COVID-19 patients
Antimicrobial Stewardship & Healthcare Epidemiology, 2023 Objective: To describe the characteristics and find out risk factors of COVID-19 patients infected with different categories of bacteria. Design: Case-control.
Guangjie Wu +3 more
doaj +1 more source
Netilmicin in Gram-Negative Bacterial Infections [PDF]
Antimicrobial Agents and Chemotherapy, 1979 Netilmicin, a new semisynthetic aminoglycoside, was used in the treatment of 42 patients with serious gram-negative bacterial infections. Of the 40 evaluable patients, 24 (60%) were cured, and 8 (20%) had a favorable clinical response, for a total clinical response rate of 80%.
D R, Snydman +4 more
openaire +2 more sources
Treatment of Multi-Drug Resistant Gram-Negative Bacterial Pathogenic Infections
Journal of Pure and Applied Microbiology, 2020 The multidrug-resistant Gram-negative bacteria (MDR-GNB) infections in severely infected patients present numerous difficulties in terms of treatment failure where antibiotics cannot arrest such drug resistant bacteria.
Wardah Mohammad Akram +4 more
doaj +1 more source
A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections
Scientific Reports, 2021 The emergence of infections by carbapenem resistant Enterobacteriaceae (CRE) pathogens has created an urgent public health threat, as carbapenems are among the drugs of last resort for infections caused by a growing fraction of multi-drug resistant (MDR)
Justin B. Schaal +9 more
doaj +1 more source
Increased rate of multidrug-resistant gram-negative bacterial infections in hospitalized immunocompromised pediatric patients [PDF]
Frontiers in Cellular and Infection MicrobiologySarah Khafaja +2 more
exaly +2 more sources
Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections [PDF]
Drugs, 2021 Intravenous cefiderocol (Fetroja®; Fetcroja®) is the first siderophore cephalosporin approved for the treatment of adults with serious Gram-negative bacterial infections. Cefiderocol is stable against all four Ambler classes of β-lactamases (including metallo-β-lactamases) and exhibits excellent in vitro activity against many clinically relevant Gram ...
openaire +2 more sources
Emergence of Pan-drug resistance amongst gram negative bacteria! The First case series from India [PDF]
Journal of Microbiology and Infectious Diseases, 2014 Objective: Increasing prevalence of carbapenem resistant Gram negative bacteria is a serious clinical and public health challenge. Bacteria resistant to all available antibiotics (Pan Drug Resistance) herald the onset of post antibiotics era. We hereby
Abdul Ghafur +4 more
doaj +1 more source